eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
4/2024
vol. 11
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Opis przypadku

Successful desensitization with 5-fluorouracil in a patient who developed anaphylaxis after 5-fluorouracil infusion

Mehmet Erdem Çakmak
1
,
Nida Oztop
1
,
Osman Ozan Yeğit
1

  1. Department of Allergy and Clinical Immunology, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey
Alergologia Polska – Polish Journal of Allergology 2024; 11, 4: 339–341
Data publikacji online: 2024/08/12
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


5-Fluorouracil (5-FU) is a chemotherapeutic agent widely used in the treatment of gastrointestinal tract, skin and breast cancers. Hypersensitivity reactions may occur due to the use of chemotherapeutic drugs. The underlying mechanisms of hypersensitivity reactions to chemotherapeutic drugs are not clear and depend on the drugs. Hypersensitivity reactions may develop with both immunological and non-immunological mechanisms. 5-FU infusion chemotherapy may cause early types of life-threatening hypersensitivity reactions. If 5-FU infusion chemotherapy must be administered after an allergic reaction, it should be administered with a desensitization protocol. Life-threatening hypersensitivity reactions to 5-FU are rare in the literature. The case is here presented of a patient with metastatic gastric cancer who developed anaphylaxis during systemic 5-FU administration and was successfully desensitized to 5-FU.


© 2024 Termedia Sp. z o.o.
Developed by Bentus.